Drug packaging / filling operations

paulag

Involved In Discussions
Dear all,

One of our facilities manufactures primary packaging containers such as ampoules, their processes are GMP compliant, everything OK so far.

As a strategic vision, this plant shall be enabled to also perform pharmaceutical packaging / filling operations for the EU and US market.

How can we best perform a gap analysis on what we need to install, implement, qualify, train, etc, to avoid any noncompliance for future packaging operations?

Thank you in advance for every red thread I could follow...

Best regards

:thanx:
 

Marc

Fully vaccinated are you?
Leader
The first question is, have you determined all applicable standards and regulations, and do you have copies of them?
 

paulag

Involved In Discussions
Hi Marc,

They are ISO 13485 and 15378 certified, do pretty well in audits, follow the cleanroom and hygiene standards, - not sure about other technical standards, though...
 

Marc

Fully vaccinated are you?
Leader
<snip> How can we best perform a gap analysis on what we need to install, implement, qualify, train, etc, to avoid any noncompliance for future packaging operations? <snip>
Drugs are not my area of expertise, but as far as gap analysis - I assume it would be like other fields (my answer is thus general). I would make a matrix of all requisite standards, regulations, etc. and do the analysis against it.

I'm not sure how many pharm people visit here regularly, but hopefully one can be more specific.
 

ScottK

Not out of the crisis
Leader
Super Moderator
Having been audited nearly monthly by big pharma companies over the last 2 years, I can tell you that drug manufacturers in the US don't much care about ISO 13485 at this time.
They care far more about 21 CRF Part 210 for you're offering.

If I was in your shoes I would hire a consultant to do a gap analysis. Preferably a consultant who was once an FDA drug inspector.
 

Ajit Basrur

Leader
Admin
Hi Marc,

They are ISO 13485 and 15378 certified, do pretty well in audits, follow the cleanroom and hygiene standards, - not sure about other technical standards, though...

I think you are looking at wrong standards - ISO 13485 is purely on medical devices, while the ISO 15378 refers to primary packaging materials for medicinal products.

As Scott mentioned, refer to

21 CFR Part 210

21 CFR Part 211

Also refer to ICH (International Conference on harmonization) documents, namely

ICH Q8, Pharmaceutical Development

ICH, Q9, Quality Risk management

ICH, Q10, Pharmaceutical Quality System

The above documents will bring you closer to the Drug filling and packaging operations.
 

v9991

Trusted Information Resource
I think you are looking at wrong standards - ISO 13485 is purely on medical devices, while the ISO 15378 refers to primary packaging materials for medicinal products.

As Scott mentioned, refer to

21 CFR Part 210

21 CFR Part 211

Also refer to ICH (International Conference on harmonization) documents, namely

ICH Q8, Pharmaceutical Development

ICH, Q9, Quality Risk management

ICH, Q10, Pharmaceutical Quality System

The above documents will bring you closer to the Drug filling and packaging operations.

From systems point of view ISO 13485 and 15378 could be adequate. Need to add specific systems for stability studies-shelf life, reserve samples, testing-release & distribution, tamper evident packaging, testing, approval/rejection of components, reserve samples etc.
above is outlined in diff context but with the scope of ISO & 13485 in following document.

for product, ensure compliance to general chapters of USP and EP is required; although they might be related to registration/ dossier related information, certain controls to be ensured and evaluated.
you can access the general chapters in the final stages of draft at USPPF.com. ( its free to register and access)

https://ipacrs.org/assets/uploads/outputs/6_-_USP_Packaging_Update_Stults.pdf

USP Q&A: Standards for Plastic Packaging Systems for Drug Products | Quality Matters | U.S. Pharmacopeia Blog
and certain ref include....
General Chapter <661> Plastic Packaging Systems and their Materials of Construction:
General Chapter <1663> Assessment of Extractables Associated with Pharmaceutical Packaging/Delivery Systems
General Chapter <1664> Assessment of Drug Product Leachables Associated with Pharmaceutical Packaging/Delivery Systems
〈1177〉 good packaging practices - USP
<659> Packaging and Storage Requirements Type of ... - USP-NF
 

Attachments

  • 6_-_USP_Packaging_Update_Stults.pdf
    286.1 KB · Views: 239
Thread starter Similar threads Forum Replies Date
P Looking for Korean FDA Drug Master File requirements for packaging systems. Other Medical Device and Orthopedic Related Topics 1
P China drug packaging DMF China Medical Device Regulations 0
I Drug Products - Packaging and Labeling Operations Requirements - 211.130 Pharmaceuticals (21 CFR Part 210, 21 CFR Part 211 and related Regulations) 1
M Any company who can provide hollow micrometer transferable patches for drug delivery? Other Medical Device and Orthopedic Related Topics 1
B Regulatory Reference for Controlled Drug Manufacturer Supplier Quality Assurance and other Supplier Issues 0
V Regulatory consultants for US FDA ANDA - pharma / drug products Consultants and Consulting 0
G RAC Drug 2023 Spring Preparation General Information Resources 0
M DHF for drug products Pharmaceuticals (21 CFR Part 210, 21 CFR Part 211 and related Regulations) 0
M Drug-Device Combination product CE Marking (Conformité Européene) / CB Scheme 1
H OTC DRUG Private Labelling Distributor: GMP REQUIREMENT ISO 13485:2016 - Medical Device Quality Management Systems 0
M How to Develop a Sampling Plan for Drug Substance? Inspection, Prints (Drawings), Testing, Sampling and Related Topics 0
N Is this a single integral drug device combination product EU MDR CE Marking (Conformité Européene) / CB Scheme 1
D CFR Title 14: Aeronautics and Space PART 120—DRUG AND ALCOHOL TESTING PROGRAM Federal Aviation Administration (FAA) Standards and Requirements 3
Q Legal Manufacturer OTC Drug Pharmaceuticals (21 CFR Part 210, 21 CFR Part 211 and related Regulations) 0
D CE Marked product considered a Drug in India Other Medical Device Regulations World-Wide 0
M Workplace Drug Testing in 2020 Misc. Quality Assurance and Business Systems Related Topics 19
T Clinical trial - Medical device product not cleared (without FDA approval) in a drug trial Other US Medical Device Regulations 9
D Requirement of Pharmacovigilance (Drug Safety) Risk Based Strategic and Tactical Audit Plan General Auditing Discussions 0
V Informational EMA - Quality requirements for drug-device combinations EU Medical Device Regulations 0
M Informational Health Canada – Drug and medical device highlights 2018: Helping you maintain and improve your health Medical Device and FDA Regulations and Standards News 1
kashmunnee1 Comparator drug with Japanese label use in Clinical trials? US Food and Drug Administration (FDA) 0
S Do we need to validate Software used in Drug discovery and development process? Qualification and Validation (including 21 CFR Part 11) 2
O Validation approach for a Photostability Chamber (used for fluid therapy and injectable drug products) Qualification and Validation (including 21 CFR Part 11) 1
M Informational MHRA Guidance – Recommendations from the independent Expert Advisory Group on the use of Paclitaxel Drug-Coated Balloons (DCBs) and Drug-Eluting Stent Medical Device and FDA Regulations and Standards News 0
K Release testing for Combination Drug-Medical Device Pharmaceuticals (21 CFR Part 210, 21 CFR Part 211 and related Regulations) 0
D FDA filing guidance to add sterilization step for approved drug Pharmaceuticals (21 CFR Part 210, 21 CFR Part 211 and related Regulations) 8
M FDA News USFDA Final Rule – Medical Device Classification Procedures: Incorporating Food and Drug Administration Safety and Innovation Act Procedures Medical Device and FDA Regulations and Standards News 0
S Should the primary drug containers be molded in ISO Class 7 clean room? Pharmaceuticals (21 CFR Part 210, 21 CFR Part 211 and related Regulations) 6
H Korea DMF (Drug Master File) Fees Various Other Specifications, Standards, and related Requirements 5
Y What Clinical Data is required for Drug Delivery System EU Medical Device Regulations 1
P DMF (Drug Master File) type V for Sterilization Processes for USFDA Submission Other US Medical Device Regulations 3
V For a Drug-Device Combination Product, 'Design Control' Process is triggered at? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
A Russia- Medical device with drug registration Other Medical Device Regulations World-Wide 0
Y Shelf Life of Non-Sterile Disposable Drug Inhaler 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
V Design Controls for Combination Drug Product Manufacturer (ANDA) 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
V Upgrading Systems from CFR 211 to CFR 820 (drug+device combination) 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 7
L Registration of an Imported Medical Drug in Turkey Pharmaceuticals (21 CFR Part 210, 21 CFR Part 211 and related Regulations) 1
R Holding time stability study of intermediates of drug substances US Food and Drug Administration (FDA) 2
S Korea - MFDS (South Korea Ministry of Food and Drug Safety) Contact? Other Medical Device Regulations World-Wide 10
D Risk Management for Drug-Device Combinations ISO 14971 - Medical Device Risk Management 1
J CFDA issues Guiding Opinions on Enhancing the Construction of Food and Drug Inspectio China Medical Device Regulations 1
S Can I view listed drug products on FDA website similar to listed medical devices? Pharmaceuticals (21 CFR Part 210, 21 CFR Part 211 and related Regulations) 4
E Operational Qualification of a Drug Box Coding Device in Production Other Medical Device and Orthopedic Related Topics 1
B Environmental Monitoring for Biopharmaceutical Manufacturing of Bulk Drug Substances Other ISO and International Standards and European Regulations 1
A Comparing US/FDA Drug Regulations against US/FDA Device Regulations US Food and Drug Administration (FDA) 3
R Drug Stability Data at the time of Filing US Food and Drug Administration (FDA) 3
Ajit Basrur FDA - Guidance for Industry - Generic Drug User Fee Amendments of 2012 - Q & A US Food and Drug Administration (FDA) 0
V Variations - Changes to Approved Dossiers - Drug Product US Food and Drug Administration (FDA) 0
Ajit Basrur Cancer drug prices may fall by up to 80% in India! Coffee Break and Water Cooler Discussions 1
Ajit Basrur Guidance for Industry - Delaying, Denying, Limiting, or Refusing a Drug Inspection US Food and Drug Administration (FDA) 3

Similar threads

Top Bottom